Cart
sales@molnova.com
SMER-18
CAS No. 944153-47-3
SMER-18( SMER18 )
Catalog No. M16762 CAS No. 944153-47-3
A small molecule autophagy enhancer that induces autophagy independently of rapamycin in mammalian cells and enhances the clearance of autophagy substrates such as mutant huntingtin and A53T alpha-synuclein; reduces toxicity in Huntington's disease models.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 360 | In Stock |
|
| 5MG | 330 | In Stock |
|
| 10MG | 471 | In Stock |
|
| 25MG | 914 | In Stock |
|
| 50MG | 1386 | In Stock |
|
| 100MG | 1841 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSMER-18
-
NoteResearch use only, not for human use.
-
Brief DescriptionA small molecule autophagy enhancer that induces autophagy independently of rapamycin in mammalian cells and enhances the clearance of autophagy substrates such as mutant huntingtin and A53T alpha-synuclein; reduces toxicity in Huntington's disease models.
-
DescriptionA small molecule autophagy enhancer that induces autophagy independently of rapamycin in mammalian cells and enhances the clearance of autophagy substrates such as mutant huntingtin and A53T alpha-synuclein; reduces toxicity in Huntington's disease models.
-
In Vitro——
-
In Vivo——
-
SynonymsSMER18
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number944153-47-3
-
Formula Weight287.7409
-
Molecular FormulaC16H14ClNO2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESOC1=C2N=C(C)C=CC2=CC=C1C(NC3=NC=CC(C)=C3)C4=CC=CC=C4[N+]([O-])=O
-
Chemical Name2-Buten-1-one, 1-(4-chlorophenyl)-3-[(3-hydroxyphenyl)amino]-, (2Z)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sarkar S, et al. Nat Chem Biol. 2007 Jun;3(6):331-8.
molnova catalog
related products
-
CA77.1
CA77.1(CA) is a novel chaperon-mediated autophagy (CMA) activator for the treatment of Alzheimer's disease (AD).
-
MK-8719
MK-8719 is a highly potent and selective inhibitor of O-GlcNAcase (OGA) (hOGA, Ki=7.9 nM) .
-
LYN-1604 2HCl 221675...
LYN-1604 is a novel ULK1 activator.It inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604, to be the best candidate for a ULK1 agonist.?LYN-1604 induced cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604 has potential for good therapeutic effects on TNBC by targeting ULK1-modulated cell death in vivo.
